title: Mice Abundant in Muricholic Bile Acids Show Resistance to Dietary Induced Steatosis, Weight Gain, and to Impaired Glucose Metabolism.
abstract: High endogenous production of, or treatment with muricholic bile acids, strongly reduces the absorption of cholesterol. Mice abundant in muricholic bile acids may therefore display an increased resistance against dietary induced weight gain, steatosis, and glucose intolerance due to an anticipated general reduction in lipid absorption. To test this hypothesis, mice deficient in steroid 12-alpha hydroxylase (Cyp8b1-/-) and therefore abundant in muricholic acids were monitored for 11 weeks while fed a high fat diet. Food intake and body and liver weights were determined, and lipids in liver, serum and feces were measured. Further, responses during oral glucose and intraperitoneal insulin tolerance tests were evaluated. On the high fat diet, Cyp8b1-/- mice displayed less weight gain compared to wildtype littermates (Cyp8b1+/+). In addition, liver enlargement with steatosis and increases in serum LDL-cholesterol were strongly attenuated in Cyp8b1-/- mice on high fat diet. Fecal excretion of cholesterol was increased and there was a strong trend for doubled fecal excretion of free fatty acids, while excretion of triglycerides was unaltered, indicating dampened lipid absorption. On high fat diet, Cyp8b1-/- mice also presented lower serum glucose levels in response to oral glucose gavage or to intraperitoneal insulin injection compared to Cyp8b1+/+. In conclusion, following exposure to a high fat diet, Cyp8b1-/- mice are more resistant against weight gain, steatosis, and to glucose intolerance than Cyp8b1+/+ mice. Reduced lipid absorption may in part explain these findings. Overall, the results suggest that muricholic bile acids may be beneficial against the metabolic syndrome.
authors.affiliation: Department of Medicine, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.|Department of Biosciences and Nutrition, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.
authors.forename: Ylva
authors.initials: Y
authors.lastname: Bonde
authors.affiliation: Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.
authors.forename: Gösta
authors.initials: G
authors.lastname: Eggertsen
authors.affiliation: Department of Medicine, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.|Department of Biosciences and Nutrition, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.
authors.forename: Mats
authors.initials: M
authors.lastname: Rudling
mesh_terms: D000818:Animals; D002784:Cholesterol / Q000378:metabolism; D002793:Cholic Acids / Q000378:metabolism*; D059305:Diet, High-Fat / Q000009:adverse effects; D005234:Fatty Liver / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D005260:Female; D017353:Gene Deletion; D005947:Glucose / Q000378:metabolism*; D018149:Glucose Intolerance / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000378:metabolism / Q000473:pathology*; D008297:Male; D051379:Mice; D013253:Steroid 12-alpha-Hydroxylase / Q000235:genetics; D015430:Weight Gain
chemical_list: D002793:Cholic Acids; C004821:muricholic acid; D002784:Cholesterol; D013253:Steroid 12-alpha-Hydroxylase; D005947:Glucose
references.citation: J Clin Invest. 2002 Oct;110(8):1191-200
references.pmid: 12393855
references.citation: Dig Dis. 2015;33(3):376-81
references.pmid: 26045272
references.citation: Eur J Biochem. 1983 Jul 15;134(1):191-6
references.pmid: 6861760
references.citation: Am J Epidemiol. 1990 Jan;131(1):20-31
references.pmid: 2293749
references.citation: Biochim Biophys Acta. 2005 Aug 15;1735(3):167-75
references.pmid: 15994119
references.citation: Eur J Clin Invest. 2006 Feb;36(2):98-104
references.pmid: 16436091
references.citation: Nature. 2006 Jan 26;439(7075):484-9
references.pmid: 16400329
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):979-84
references.pmid: 17210919
references.citation: Gastroenterology. 2008 Apr;134(4):1127-36
references.pmid: 18395092
references.citation: FASEB J. 2008 Jul;22(7):2416-26
references.pmid: 18326786
references.citation: J Lipid Res. 2010 Nov;51(11):3230-42
references.pmid: 20671298
references.citation: FASEB J. 2010 Dec;24(12):4948-59
references.pmid: 20724524
references.citation: Biochim Biophys Acta. 2011 Aug;1812(8):888-92
references.pmid: 21167938
references.citation: Cell Metab. 2013 Feb 5;17(2):225-35
references.pmid: 23395169
references.citation: Gut. 2013 Jun;62(6):899-910
references.pmid: 23292666
references.citation: Cell Host Microbe. 2013 Nov 13;14(5):582-90
references.pmid: 24237703
references.citation: J Intern Med. 2014 Jan;275(1):27-38
references.pmid: 24118394
references.citation: Curr Opin Gastroenterol. 2014 May;30(3):332-8
references.pmid: 24625896
references.citation: PLoS One. 2014;9(5):e97426
references.pmid: 24841254
references.citation: Nat Rev Endocrinol. 2014 Aug;10(8):488-98
references.pmid: 24821328
references.citation: J Biol Chem. 2014 Oct 31;289(44):30470-80
references.pmid: 25204652
references.citation: Diabetes. 2015 Apr;64(4):1168-79
references.pmid: 25338812
references.citation: Am J Physiol Gastrointest Liver Physiol. 2003 Sep;285(3):G494-502
references.pmid: 12748061